TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - HIV-Associated Neurodegeneration

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS, NIMH, and NIA request applications for research on the pathophysiology of HIV-associated neurodegeneration in aging populations on long-term anti-retroviral therapy.  This announcement is supported by 2 funding mechanisms:  R01 and R21.

The Centers for Disease Control and Prevention projects that by 2015, more than half of all HIV-infected individuals in the U.S. will be over age 50.  Coupled with the aging process, the extended exposure of these adults to both HIV and antiretroviral drugs appears to increase their risk of illness and death from cardiovascular, bone, kidney, liver, lung, neurological, and neuropsychiatric complications.  This announcement will stimulate research on the pathophysiology and treatment of HIV-associated neurocognitive disorders in HIV-infected people over age 50 who are on highly active antiretroviral therapy.

Letters of Intent Due August 9, 2011

Applications Due September 9, 2011

Potential applicants should contact Dr. May Wong, program director, Neural Environment Cluster, NINDS, at 301-496-1431 or  For more information visit or